Persistence with asthma treatment is low in Germany especially for controller medication - A population based study of 483 051 patients

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 65, Issue 3, 2010, Pages 347-354

  Hasford, J ^a   Uricher, J ^a   Tauscher, M ^b   Bramlage, P ^c   Virchow, J C ^d  

^a UNIVERSITY OF MUNICH   (Germany)

^b Kassenarztliche Vereinigung Bayerns   (Germany)

^c Institute for Cardiovascular Pharmacology and Epidemiology   (Germany)

^d ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

Author keywords

Asthma; Defined daily doses; Inhaled corticosteroids; Long acting beta agonists; Persistence

Indexed keywords

AEROMAX DA; APSOMOL; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETAMETHASONE DIPROPIONATE; BUDEFAST; BUDESONIDE; BUDESONIDE PLUS FORMOTEROL; CELESTAMINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CICLESONIDE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; FLUNISOLIDE; FLUTICASONE PROPIONATE; FLUTICASONE PROPIONATE PLUS SALMETEROL; FORADIL DA; FORMOTEROL FUMARATE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LONG ACTING DRUG; MOMETASONE FUROATE; OXIS DA; SALBUTAMOL; SALMETEROL XINAFOATE; SEVERENT DA; SHORT ACTING DRUG; UNCLASSIFIED DRUG; XANTHINE DERIVATIVE;

ADULT; AGED; AMBULATORY CARE; ARTICLE; ASTHMA; DRUG EFFICACY; DRUG USE; FEMALE; GERMANY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; POPULATION RESEARCH; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; SEX DIFFERENCE;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ADRENERGIC BETA-AGONISTS; ADULT; ANTI-ASTHMATIC AGENTS; ASTHMA; FEMALE; GERMANY; GUIDELINE ADHERENCE; GUIDELINES AS TOPIC; HUMANS; MALE; PHYSICIAN'S PRACTICE PATTERNS; PREVALENCE; YOUNG ADULT;

EID: 76249114680     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2009.02161.x     Document Type: Article

References (24)

1. Masoli M, Fabian D, Holt S, Beasley R. The global burden of asthma, executive summary of the GINA Dissemination Committee report. Allergy 2004 59 : 469 478.
2. Weißbuch Lunge. Die Lunge und ihre Erkrankungen, Zur Lage und Zukunft der Pneumologie in Deutschland. Stuttgart : Georg Thieme Verlag, 2000.
3. Vogelmeier C, Buhl R, Criee CP, Gillissen A, Kardos P, Kohler D et al. Guidelines for the diagnosis and therapy of COPD issued by Deutsche Atemwegsliga and Deutsche Gesellschaft fur Pneumologie und Beatmungsmedizin. Pneumologie 2007 61 : e1 40.
4. British Thoracic Society. British Guideline on the Management of Asthma. Thorax 2008 63 (Suppl 4 iv1 iv121.
5. van der Molen T, Ostrem A, Stallberg B, Ostergaard MS, Singh RB. International Primary Care Respiratory Group (IPCRG) Guidelines, management of asthma. Prim Care Respir J 2006 15 : 35 47.
6. Bateman E. Global Strategy for Asthma Management and Prevention 2008 (update). 2008 [cited 2008 23.01.2009]; Available from: http://www.ginasthma. com/Guidelineitem.aspl1=2&l2=1&intId=1561
7. Rabe KF, Vermeire PA, Soriano JB, Maier WC. Clinical management of asthma in 1999, the Asthma Insights and Reality in Europe (AIRE) study. Eur Respir J 2000 16 : 802 807.
8. Lynd LD, Guh DP, Pare PD, Anis AH. Patterns of inhaled asthma medication use, a 3-year longitudinal analysis of prescription claims data from British Columbia, Canada. Chest 2002 122 : 1973 1981.
9. Bender BG, Pedan A, Varasteh LT. Adherence and persistence with fluticasone propionate/salmeterol combination therapy. J Allergy Clin Immunol 2006 118 : 899 904.
10. Chapman KR, Boulet LP, Rea RM, Franssen E. Suboptimal asthma control: prevalence, detection and consequences in general practice. Eur Respir J 2008 31 : 320 325.
11. Langen U, Knopf H, Melchert HU. Drug therapy of asthma Results of the 1998 German National Health Interview and Examination Survey. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2006 49 : 903 910.
12. Graham ID, Logan J, Harrison MB, Straus SE, Tetroe J, Caswell W et al. Lost in knowledge translation, time for a map? J Contin Educ Health Prof 2006 26 : 13 24.
13. McIvor RA, Chapman KR. The coming of age of asthma guidelines. Lancet 2008 372 : 1021 1022.
14. Speizer FE, Doll R, Heaf P. Observations on recent increase in mortality from asthma. Br Med J 1968 1 : 335 339.
15. Grainger J, Woodman K, Pearce N, Crane J, Burgess C, Keane A et al. Prescribed fenoterol and death from asthma in New Zealand, 1981-7: a further case-control study. Thorax 1991 46 : 105 111.
16. Suissa S, Blais L, Ernst P. Patterns of increasing beta-agonist use and the risk of fatal or near-fatal asthma. Eur Respir J 1994 7 : 1602 1609.
17. Suissa S, Ernst P, Boivin JF, Horwitz RI, Habbick B, Cockroft D et al. A cohort analysis of excess mortality in asthma and the use of inhaled beta-agonists. Am J Respir Crit Care Med 1994 149 : 604 610.
18. Marceau C, Lemiere C, Berbiche D, Perreault S, Blais L. Persistence, adherence, and effectiveness of combination therapy among adult patients with asthma. J Allergy Clin Immunol 2006 118 : 574 581.
19. O'Connor RD, Rosenzweig JR, Stanford RH, Gilmore AS, Ryskina KL, Legorreta AP et al. Asthma-related exacerbations, therapy switching, and therapy discontinuation, a comparison of 3 commonly used controller regimens. Ann Allergy Asthma Immunol 2005 95 : 535 540.
20. Nelson HS, Weiss ST, Bleecker ER, Yancey SW, Dorinsky PM. The Salmeterol Multicenter Asthma Research Trial, a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest 2006 129 : 15 26.
21. Hasford J, Virchow JC. Excess mortality in patients with asthma on long-acting beta2-agonists. Eur Respir J 2006 28 : 900 902.
22. Wooltorton E. Long-acting beta2-agonists in asthma, safety concerns. CMAJ 2005 173 : 1030 1031.
23. Papi A, Canonica GW, Maestrelli P, Paggiaro P, Olivieri D, Pozzi E et al. Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma. N Engl J Med 2007 356 : 2040 2052.
24. Pont LG, van der Werf GT, Denig P, Haaijer-Ruskamp FM. Identifying general practice patients diagnosed with asthma and their exacerbation episodes from prescribing data. Eur J Clin Pharmacol 2002 57 : 819 825.